| A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects (NCT02155543) | Allergan | 2014-05-01 |
| Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals (NCT02148835) | Clemens von Schacky | 2014-05-01 |
| Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine (NCT02109497) | Prana Biotechnology Limited | 2014-05-01 |
| A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years (NCT02143310) | Fontem Ventures BV | 2014-05-01 |
| A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study (NCT02175056) | Handok Inc. | 2014-05-01 |
| A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 (NCT02134834) | Meiji Seika Pharma Co., Ltd. | 2014-05-01 |
| A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg (NCT03787043) | Handok Inc. | 2014-05-01 |
| Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects (NCT02118909) | Helsinn Healthcare SA | 2014-05-01 |
| A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants (NCT02123472) | Eli Lilly and Company | 2014-05-01 |
| Biomarkers of Whole Grain Wheat and Rye Intake (NCT02155062) | King's College London | 2014-05-01 |
| A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users (NCT02144415) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-05-01 |
| Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD9291 in Volunteers (NCT02096679) | AstraZeneca | 2014-05-01 |
| Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers (NCT02121080) | Regeneron Pharmaceuticals | 2014-05-01 |
| A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan (NCT02088008) | IlDong Pharmaceutical Co Ltd | 2014-05-01 |
| Evaluation of the Effect of Benzonatate on QT Intervals Following Single Dose Administration of Benzonatate to Healthy Volunteers (NCT02207699) | Pfizer | 2014-05-01 |
| Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2 (NCT02107313) | Prana Biotechnology Limited | 2014-05-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects (NCT02155504) | Astellas Pharma Europe B.V. | 2014-05-01 |
| To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers (NCT02140281) | Ardelyx | 2014-05-01 |
| Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus (NCT02106897) | Biogen | 2014-04-30 |
| Study to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers (NCT02373891) | Hyundai Pharmaceutical Co., LTD. | 2014-04-01 |
| Photoallergy Potential of Dapsone Gel in Healthy Volunteers (NCT02117739) | Almirall, S.A. | 2014-04-01 |
| Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers (NCT02374437) | Galmed Pharmaceuticals Ltd | 2014-04-01 |
| Dermal Tolerability of Dapsone Gel in Healthy Volunteers (NCT02117752) | Almirall, S.A. | 2014-04-01 |
| A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662 (NCT02194491) | Astellas Pharma Global Development, Inc. | 2014-04-01 |
| A Study of Cephalexin Capsules in Healthy Participants (NCT02123446) | Eli Lilly and Company | 2014-04-01 |
| Effects of Soluble Phosphate in Humans (NCT02095392) | University of Jena | 2014-04-01 |
| 1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer (NCT02700776) | University of Maryland, Baltimore | 2014-04-01 |
| AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study (NCT02063386) | Ardelyx | 2014-04-01 |
| Phototoxicity Test of Dapsone Gel in Healthy Volunteers (NCT02108483) | Almirall, S.A. | 2014-04-01 |
| Assessment of the Effect of n-3(Omega 3) Fortified Egg in Healthy Subjects (NCT01565252) | Rabin Medical Center | 2014-04-01 |
| A Study of Cephalexin in Healthy Participants (NCT02100826) | Eli Lilly and Company | 2014-04-01 |
| Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine (NCT02038907) | Takeda | 2014-03-28 |
| Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8 (NCT02108015) | National Institute of Mental Health (NIMH) | 2014-03-05 |
| Depotentiation in People With Focal Hand Dystonia (NCT02106936) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-03-05 |
| Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers (NCT02063594) | Marval Pharma Ltd. | 2014-03-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects (NCT02141425) | Astellas Pharma Global Development, Inc. | 2014-03-01 |
| Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects (NCT02122692) | H. Lundbeck A/S | 2014-03-01 |
| Phase III Study of Intramuscular TAK-816 in Healthy Infants (NCT02074345) | Takeda | 2014-03-01 |
| ABX464 First in Man Study (NCT02792686) | Abivax S.A. | 2014-03-01 |
| Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate (NCT01950520) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-02-07 |
| Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers (NCT02091310) | Genfit | 2014-02-01 |
| Influence of Gravity on the Perception of Egocentric Distance (Blindpulling) (NCT02508545) | University Hospital, Caen | 2014-02-01 |
| Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects (NCT02039180) | AstraZeneca | 2014-02-01 |
| A Study of LY2835219 in Healthy Participants (NCT02059148) | Eli Lilly and Company | 2014-02-01 |
| Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects (NCT02058784) | Helsinn Healthcare SA | 2014-02-01 |
| Copanlisib Mass Balance Study (NCT02119221) | Bayer | 2014-02-01 |
| A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components (NCT02065752) | Janssen Research & Development, LLC | 2014-02-01 |
| First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001 (NCT02110420) | Celgene Corporation | 2014-02-01 |
| A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components (NCT02073227) | Janssen Research & Development, LLC | 2014-02-01 |
| A Clinical Study for Evaluating the Safety of a Plant Sterol-enriched Fermented Dairy Product in Japanese Healthy Adults (NCT02278393) | Danone Japan | 2014-02-01 |
| Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men (NCT02236988) | Amgen | 2014-01-07 |
| Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438) (NCT02037477) | Takeda | 2014-01-01 |
| Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination (NCT02039245) | Janssen Research & Development, LLC | 2014-01-01 |
| A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects (NCT02039089) | Eisai Inc. | 2014-01-01 |
| Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy Volunteers (NCT02062203) | Akebia Therapeutics | 2014-01-01 |
| A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs (NCT03787017) | Handok Inc. | 2014-01-01 |
| Effect of Sucrose on Liver Fat (NCT02015442) | Imperial College London | 2014-01-01 |
| Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials (NCT02297490) | Allergopharma GmbH & Co. KG | 2014-01-01 |
| Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food (NCT02039258) | Janssen Research & Development, LLC | 2014-01-01 |
| Study of the Effect of a Very-Low-Carbohydrate Diet on Energy Expenditure (NCT01967563) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2013-12-03 |
| A Study to Evaluate the Safety Profile of an e-Vapour Product (NCT02029196) | Imperial Brands PLC | 2013-12-01 |
| Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly (NCT02147548) | Biocodex | 2013-12-01 |
| A Study of Insulin Peglispro in Healthy Male Japanese Participants (NCT01995526) | Eli Lilly and Company | 2013-12-01 |
| A Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product (NCT02032212) | Imperial Brands PLC | 2013-12-01 |
| A Study of LY2969822 in Healthy Participants (NCT02018887) | Eli Lilly and Company | 2013-12-01 |
| A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate (NCT02010970) | AstraZeneca | 2013-12-01 |
| A Study of Axiron® in Healthy Participants (NCT02004132) | Eli Lilly and Company | 2013-12-01 |
| A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects (NCT02088697) | Otsuka Pharmaceutical Co., Ltd. | 2013-12-01 |
| A Phase 1 Study of the Pharmacokinetics of RDC5 in Healthy Volunteers (NCT02016742) | Chronos Therapeutics Ltd | 2013-12-01 |
| Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions (NCT03603106) | Guerbet | 2013-11-25 |
| Bedside Respiratory Patient Monitoring System - Sensor Off Study (NCT02075346) | Medtronic - MITG | 2013-11-01 |
| Neurophysiological Study of tDCS Effects in Healthy Volunteers (NCT02125422) | University of Liege | 2013-11-01 |
| Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers (NCT01982604) | Mannkind Corporation | 2013-11-01 |
| Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects (NCT01986608) | UCB Pharma SA | 2013-11-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants (NCT01964872) | Janssen Cilag N.V./S.A. | 2013-11-01 |
| The Effects of the Synbiotic Ecologic 825/scFOS on Intestinal Barrier Function and Immune Modulation (NCT02018900) | Maastricht University Medical Center | 2013-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients (NCT02048358) | BBB-Therapeutics B.V. | 2013-11-01 |
| A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers (NCT01989455) | ApoPharma | 2013-11-01 |
| Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers (NCT01980615) | Pearl Therapeutics, Inc. | 2013-11-01 |
| CYP2B6 Polymorphisms in Ketamine (NCT01988922) | Washington University School of Medicine | 2013-11-01 |
| Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers (NCT01981746) | Rigshospitalet, Denmark | 2013-11-01 |
| A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers (NCT01980303) | Janssen Research & Development, LLC | 2013-11-01 |
| The Brain Alerting Mechanism Study (NCT02050386) | University of Florida | 2013-11-01 |
| A Study of LY2801653 in Healthy Participants (NCT01981408) | Eli Lilly and Company | 2013-11-01 |
| Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions (NCT01974427) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-10-26 |
| To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food. (NCT01951599) | AstraZeneca | 2013-10-09 |
| A Study of Baricitinib and Ciclosporin in Healthy Participants (NCT01968057) | Eli Lilly and Company | 2013-10-01 |
| A Study of [14C]-LY3023703 in Healthy Participants (NCT01965782) | Eli Lilly and Company | 2013-10-01 |
| Neural Development of Deductive Reasoning (NCT02763657) | Hospices Civils de Lyon | 2013-10-01 |
| A Study of LY3127760 in Healthy Participants (NCT01968070) | Eli Lilly and Company | 2013-10-01 |
| Population Pharmacokinetics and Pharmacodynamics Modeling to Optimize Dosage Regimen of Levofloxacin (NCT02699658) | Prince of Songkla University | 2013-10-01 |
| A Study of Baricitinib and Simvastatin in Healthy Participants (NCT01960140) | Eli Lilly and Company | 2013-10-01 |
| An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063 (NCT02370602) | Takeda | 2013-10-01 |
| Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients (NCT02746783) | University of Lausanne Hospitals | 2013-10-01 |
| A Study of LY2157299 in Healthy Participants (NCT01965808) | Eli Lilly and Company | 2013-10-01 |
| A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects (NCT01920399) | Pfizer | 2013-10-01 |
| Study to Investigate the Absolute Bioavailability of Oral Sylibin (NCT02633696) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2013-10-01 |
| A Study of Baricitinib and Omeprazole in Healthy Participants (NCT01925144) | Eli Lilly and Company | 2013-10-01 |
| Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients (NCT01970618) | Respivert Ltd | 2013-10-01 |
| A Study of Evacetrapib in Japanese and Non-Japanese Participants (NCT01958489) | Eli Lilly and Company | 2013-10-01 |